Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships

BACKGROUND: Enzyme replacement therapy (ERT) with laronidase, (recombinant human α-L-iduronidase; Aldurazyme) is the primary treatment option for patients with attenuated mucopolysaccharidosis type I (MPS I). This study examined the effect of early ERT on clinical manifestations. METHODS: This multi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Sannaa, Nouriya A., Bay, Luisa, Barbouth, Deborah S., Benhayoun, Youssef, Goizet, Cyril, Guelbert, Norberto, Jones, Simon A., Kyosen, Sandra Obikawa, Martins, Ana Maria, Phornphutkul, Chanika, Reig, Celia, Pleat, Rebecca, Fallet, Shari, Ivanovska Holder, Iva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597395/
https://www.ncbi.nlm.nih.gov/pubmed/26446585
http://dx.doi.org/10.1186/s13023-015-0344-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597395/
https://www.ncbi.nlm.nih.gov/pubmed/26446585
http://dx.doi.org/10.1186/s13023-015-0344-4

Ejemplares similares